BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 14578165)

  • 1. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties.
    Horn EJ; Albor A; Liu Y; El-Hizawi S; Vanderbeek GE; Babcock M; Bowden GT; Hennings H; Lozano G; Weinberg WC; Kulesz-Martin M
    Carcinogenesis; 2004 Feb; 25(2):157-67. PubMed ID: 14578165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB.
    Albor A; El-Hizawi S; Horn EJ; Laederich M; Frosk P; Wrogemann K; Kulesz-Martin M
    J Biol Chem; 2006 Sep; 281(35):25850-66. PubMed ID: 16816390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel initiation genes in squamous cell carcinomagenesis: a role for substrate-specific ubiquitylation in the control of cell survival.
    Albor A; Kulesz-Martin M
    Mol Carcinog; 2007 Aug; 46(8):585-90. PubMed ID: 17626251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM32 protein sensitizes cells to tumor necrosis factor (TNFα)-induced apoptosis via its RING domain-dependent E3 ligase activity against X-linked inhibitor of apoptosis (XIAP).
    Ryu YS; Lee Y; Lee KW; Hwang CY; Maeng JS; Kim JH; Seo YS; You KH; Song B; Kwon KS
    J Biol Chem; 2011 Jul; 286(29):25729-38. PubMed ID: 21628460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the Zn-Binding Domains of TRIM32, the E3 Ubiquitin Ligase Mutated in Limb Girdle Muscular Dystrophy 2H.
    Lazzari E; El-Halawany MS; De March M; Valentino F; Cantatore F; Migliore C; Onesti S; Meroni G
    Cells; 2019 Mar; 8(3):. PubMed ID: 30884854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin.
    Kudryashova E; Kudryashov D; Kramerova I; Spencer MJ
    J Mol Biol; 2005 Nov; 354(2):413-24. PubMed ID: 16243356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WOX1 is essential for UVB irradiation-induced apoptosis and down-regulated via translational blockade in UVB-induced cutaneous squamous cell carcinoma in vivo.
    Lai FJ; Cheng CL; Chen ST; Wu CH; Hsu LJ; Lee JY; Chao SC; Sheen MC; Shen CL; Chang NS; Sheu HM
    Clin Cancer Res; 2005 Aug; 11(16):5769-77. PubMed ID: 16115915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma.
    Luo Q; Wu X; Nan Y; Chang W; Zhao P; Zhang Y; Su D; Liu Z
    Cell Rep; 2020 Jan; 30(1):98-111.e5. PubMed ID: 31914402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tripartite motif protein 32 facilitates cell growth and migration via degradation of Abl-interactor 2.
    Kano S; Miyajima N; Fukuda S; Hatakeyama S
    Cancer Res; 2008 Jul; 68(14):5572-80. PubMed ID: 18632609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the psoriatic chemokine CCL20 by E3 ligases Trim32 and Piasy in keratinocytes.
    Liu Y; Lagowski JP; Gao S; Raymond JH; White CR; Kulesz-Martin MF
    J Invest Dermatol; 2010 May; 130(5):1384-90. PubMed ID: 20054338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin facilitates ultraviolet B-induced squamous cell carcinoma development.
    Chang PL; Hsieh YH; Wang CC; Juliana MM; Tsuruta Y; Timares L; Elmets C; Ho KJ
    J Dermatol Sci; 2014 Aug; 75(2):121-32. PubMed ID: 24888687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UVB-induced apoptosis drives clonal expansion during skin tumor development.
    Zhang W; Hanks AN; Boucher K; Florell SR; Allen SM; Alexander A; Brash DE; Grossman D
    Carcinogenesis; 2005 Jan; 26(1):249-57. PubMed ID: 15498793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM32 promotes neural differentiation through retinoic acid receptor-mediated transcription.
    Sato T; Okumura F; Kano S; Kondo T; Ariga T; Hatakeyama S
    J Cell Sci; 2011 Oct; 124(Pt 20):3492-502. PubMed ID: 21984809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tripartite motif 32 prevents pathological cardiac hypertrophy.
    Chen L; Huang J; Ji Y; Zhang X; Wang P; Deng K; Jiang X; Ma G; Li H
    Clin Sci (Lond); 2016 May; 130(10):813-28. PubMed ID: 26884348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation.
    Sano S; Chan KS; Kira M; Kataoka K; Takagi S; Tarutani M; Itami S; Kiguchi K; Yokoi M; Sugasawa K; Mori T; Hanaoka F; Takeda J; DiGiovanni J
    Cancer Res; 2005 Jul; 65(13):5720-9. PubMed ID: 15994947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and the potential functions of TRIM32 in lung cancer tumorigenesis.
    Yin H; Li Z; Chen J; Hu X
    J Cell Biochem; 2019 Apr; 120(4):5232-5243. PubMed ID: 30378152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of CIRP in inhibition of keratinocytes growth arrest and apoptosis following low dose UVB radiation.
    Liao Y; Feng J; Zhang Y; Tang L; Wu S
    Mol Carcinog; 2017 Jun; 56(6):1554-1569. PubMed ID: 27864909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
    Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
    Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice.
    Wikonkal NM; Remenyik E; Knezevic D; Zhang W; Liu M; Zhao H; Berton TR; Johnson DG; Brash DE
    Nat Cell Biol; 2003 Jul; 5(7):655-60. PubMed ID: 12833065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis.
    Sutton SK; Cheung BB; Massudi H; Tan O; Koach J; Mayoh C; Carter DR; Marshall GM
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2241-2250. PubMed ID: 31342168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.